13-valent Pneumococcal Conjugate Vaccine Study in Adults => 50 Years of Age in Mexico

Mise à jour : Il y a 4 ans
Référence : NCT01432262

Femme et Homme

  • | Pays :
  • Mexico
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The purpose of this study will be to assess the safety, tolerability, and immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) when given to healthy adults older than 50 years of age who haven't received 23-valent pneumococcal polysaccharide vaccine in Mexico.


Critère d'inclusion

  • Pneumococcal Infections

Liens